Skip to main content
NCBI home page
Gut logoLink to Gut
. 1987 Jul;28(7):888–895. doi: 10.1136/gut.28.7.888

Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man.

W Londong 1, V Londong 1, A Meierl 1, U Voderholzer 1
PMCID: PMC1433086  PMID: 3653758

Abstract

Telenzepine is an analogue of pirenzepine with a higher potency and similar selectivity for M1-receptors in animals. In this placebo controlled, double blind, randomised study mean peptone stimulated gastric acid secretion (mean +/- SEM) of 10 male healthy subjects (58 +/- 6 mmol H+/3 h for placebo) was significantly and dose dependently inhibited by oral telenzepine (2 mg: 31 +/- 5, 3 mg: 23 +/- 5, 5 mg: 21 +/- 4 mmol H+/3 h). Telenzepine 3 and 5 mg were significantly stronger than pirenzepine 50 mg orally (37 +/- 8 mmol H+/3 h). Mean percentage acid inhibition was 37% for pirenzepine, and 48, 61, and 64% for 2, 3, and 5 mg telenzepine, respectively. Basal and peptone stimulated gastrin release was unaffected. Mean salivary output per three hours declined moderately from 156 +/- 45 g (placebo) to 136 +/- 45 g with pirenzepine and significantly to 88 +/- 28 g, 95 +/- 39 g and 39 +/- 13 g with telenzepine 2, 3, and 5 mg, respectively. There was a parallel effect on Na+, K+, Ca++ and amylase output in saliva. Near point vision was not altered by either drug. Pulse rates were lowered by both substances. Complaints of dry mouth were more frequent with telenzepine 5 mg. On a molar basis telenzepine proved to be a 25 and 50 times more potent inhibitor of gastric and salivary secretion, respectively.

Full text

PDF
888

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker H. D. Methodischer Fortschritt in der Funktionsdiagnostik des Magens: Magensekretionsanalyse, intragastrale Titration, endokrine Provokationstests. Z Gastroenterol. 1978 Mar;16(3):118–125. [PubMed] [Google Scholar]
  2. Becker H. D., Reeder D. D., Thompson J. C. Effect of atropine on basal and food-stimulated serum gastrin levels in man. Surgery. 1974 May;75(5):701–704. [PubMed] [Google Scholar]
  3. Bodemar G., Walan A., Lundquist G. Food-stimulated acid secretion measured by intragastric titration with bicarbonate in patients with duodenal and gastric ulcer disease and in controls. Scand J Gastroenterol. 1978;13(8):911–918. doi: 10.3109/00365527809181368. [DOI] [PubMed] [Google Scholar]
  4. Carmine A. A., Brogden R. N. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases. Drugs. 1985 Aug;30(2):85–126. doi: 10.2165/00003495-198530020-00001. [DOI] [PubMed] [Google Scholar]
  5. Eltze M., Gönne S., Riedel R., Schlotke B., Schudt C., Simon W. A. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug. Eur J Pharmacol. 1985 Jun 7;112(2):211–224. doi: 10.1016/0014-2999(85)90498-4. [DOI] [PubMed] [Google Scholar]
  6. Feldman M., Richardson C. T., Taylor I. L., Walsh J. H. Effect of atropine on vagal release of gastrin and pancreatic polypeptide. J Clin Invest. 1979 Feb;63(2):294–298. doi: 10.1172/JCI109302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fink M., Irwin P. EEG and behavioral effects of pirenzepine in normal volunteers. Scand J Gastroenterol Suppl. 1980;66:39–46. [PubMed] [Google Scholar]
  8. Fordtran J. S., Walsh J. H. Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest. 1973 Mar;52(3):645–657. doi: 10.1172/JCI107226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Giachetti A., Micheletti R., Montagna E. Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. Life Sci. 1986 May 5;38(18):1663–1672. doi: 10.1016/0024-3205(86)90410-8. [DOI] [PubMed] [Google Scholar]
  10. Gillard B. K., Marksman H. C., Feig S. A. Direct spectrophotometric determination of alpha-amylase activity in salive, with p-nitrophenyl alpha-maltoside as substrate. Clin Chem. 1977 Dec;23(12):2279–2282. [PubMed] [Google Scholar]
  11. Hammer R., Giraldo E., Schiavi G. B., Monferini E., Ladinsky H. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci. 1986 May 5;38(18):1653–1662. doi: 10.1016/0024-3205(86)90409-1. [DOI] [PubMed] [Google Scholar]
  12. Konturek S. J., Biernat J., Oleksy J. Serum gastrin and gastric acid responses to meals at various pH levels in man. Gut. 1974 Jul;15(7):526–530. doi: 10.1136/gut.15.7.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Londong W. Anticholinergics for peptic ulcer--a renaissance? Hepatogastroenterology. 1982 Feb;29(1):40–46. [PubMed] [Google Scholar]
  14. Londong W., Londong V., Cederberg C., Steffen H. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology. 1983 Dec;85(6):1373–1378. [PubMed] [Google Scholar]
  15. Londong W., Londong V., Prechtl R., Weber T., von Werder K. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man. Scand J Gastroenterol Suppl. 1980;66:103–114. [PubMed] [Google Scholar]
  16. Londong W., Londong V., Ruthe C., Weizert P. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine. Gut. 1981 Jul;22(7):542–548. doi: 10.1136/gut.22.7.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Müller P., Dammann H. G., Simon B. Telenzepin hemmt dosisabhängig die durch Scheinfütterung stimulierte menschliche Säure- und Speichelsekretion. Z Gastroenterol. 1986 Mar;24(3):152–156. [PubMed] [Google Scholar]
  18. Sarkar B. C., Chauhan U. P. A new method for determining micro quantities of calcium in biological materials. Anal Biochem. 1967 Jul;20(1):155–166. doi: 10.1016/0003-2697(67)90273-4. [DOI] [PubMed] [Google Scholar]
  19. Tanswell P., Kasper W., Zahn G. Automated monoclonal radioimmunoassays for pirenzepine, a selective muscarinic receptor antagonist, in plasma and urine. J Immunol Methods. 1986 Nov 6;93(2):247–258. doi: 10.1016/0022-1759(86)90197-3. [DOI] [PubMed] [Google Scholar]
  20. Walsh J. H., Yalow R. S., Berson S. A. The effect of atropine on plasma gastrin response to feeding. Gastroenterology. 1971 Jan;60(1):16–21. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES